Close
Nordic 9Nordic 9

PEAK6 Investments (investor - Private Equity)

United States peak6.com
See something wrong or missing? Let us know
Offices:Chicago

Peak6 Investments operates as an investment management firm out of Chicago, USA

Average round investment:43.5M USD
Average number per year:1.0
Distribution: 2024 (1)2022 (1)
Portfolio companies: Netherlands MedalSwitzerland ImmunOs Therapeutics
Mostly invests in: Netherlands Netherlands (1) Media (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to PEAK6 Investments

Name Criteria
United States KB Partners
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Gaming Industry, Competitive Intelligence, Biotech, Pharma, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Venrock
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States New Science Ventures
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Competitive Intelligence, Biotech, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Netherlands Partners in Equity
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Competitive Intelligence, Pharma, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland Swiss Entrepreneurs Fund
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Norway Hadean Ventures
91%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Competitive Intelligence, Biotech, Pharma, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
United States Digital Currency Group
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Media, Gaming Industry, Competitive Intelligence
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Netherlands, Switzerland
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
United States What If Ventures
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Competitive Intelligence, Biotech, Pharma, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Invus
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Competitive Intelligence, Biotech, Pharma, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Singapore Clay Capital
90%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Competitive Intelligence, Biotech, Health services
  • Similar business models: B2C (Retail), B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top